Michael H. Goldstein serves as Executive at OCULAR THERAPEUTIX, INC, where they oversee executive responsibilities. Since joining the company, Michael H. Goldstein has executed 3 insider transactions totaling $71.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 3, 2022 involved receiving (via award) 63,333 shares valued at $0.
Michael H. Goldstein currently holds 313,335 shares of OCULAR THERAPEUTIX, INC (OCUL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael H. Goldstein has been a net buyer of OCUL stock. They have purchased $71.6K and sold $0 worth of shares.
Michael H. Goldstein's most recent insider trade was on Feb 3, 2022, when they sold 63,333 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $2.51 |
| Discretionary |
| Mar 15, 2019 | OCUL | $41.5K | Purchase | 10,000 | $4.15 | Discretionary |